{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:59:35Z","timestamp":1761058775774},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1998,7,1]],"date-time":"1998-07-01T00:00:00Z","timestamp":899251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[1998,7]]},"DOI":"10.1378\/chest.114.1.120","type":"journal-article","created":{"date-parts":[[2008,1,22]],"date-time":"2008-01-22T22:31:17Z","timestamp":1201041077000},"page":"120-130","source":"Crossref","is-referenced-by-count":53,"title":["Sparfloxacin vs Ofloxacin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis"],"prefix":"10.1016","volume":"114","author":[{"given":"C. Andrew","family":"DeAbate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Bensch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Jubran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanford","family":"Chodosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Harper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Tipping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George H.","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.114.1.120_bib1","first-page":"S77","article-title":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma","volume":"152","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl","key":"10.1378\/chest.114.1.120_bib2","doi-asserted-by":"crossref","first-page":"302S","DOI":"10.1378\/chest.96.3_Supplement.302S","article-title":"Epidemiology of chronic airways disease","volume":"96","author":"Woolcock","year":"1989","journal-title":"Chest"},{"issue":"suppl 6A","key":"10.1378\/chest.114.1.120_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0002-9343(91)90317-Q","article-title":"Treatment of acute bacterial exacerbations of chronic bronchitis: state of the art","volume":"91","author":"Chodosh","year":"1991","journal-title":"Am J Med"},{"key":"10.1378\/chest.114.1.120_bib4","first-page":"529","article-title":"Chronic bronchitis and acute infectious exacerbations","author":"Reynolds","year":"1990"},{"key":"10.1378\/chest.114.1.120_bib5","first-page":"347","article-title":"The use of antibiotics in acute bronchitis and acute bacterial exacerbations of chronic bronchitis","volume":"149","author":"Rodnick","year":"1988","journal-title":"West J Med"},{"issue":"suppl 3A","key":"10.1378\/chest.114.1.120_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0002-9343(88)90456-1","article-title":"Management of acute and chronic respiratory tract infections","volume":"85","author":"Ellner","year":"1988","journal-title":"Am J Med"},{"issue":"suppl A","key":"10.1378\/chest.114.1.120_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/37.suppl_A.1","article-title":"In vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens","volume":"37","author":"Baquero","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.114.1.120_bib8","first-page":"243","article-title":"Pro: antibiotics for chronic bronchitis with exacerbations","volume":"8","author":"Isada","year":"1993","journal-title":"Semin Respir Infect"},{"key":"10.1378\/chest.114.1.120_bib9","first-page":"189","article-title":"Chemotherapy for chronic bronchitis: controversies","volume":"24","author":"Ball","year":"1995","journal-title":"Presse Med"},{"key":"10.1378\/chest.114.1.120_bib10","first-page":"313","article-title":"Newer antimicrobial agents for use in acute bacterial exacerbations in chronic bronchitis","volume":"13","author":"Cunha","year":"1996","journal-title":"Adv Ther"},{"key":"10.1378\/chest.114.1.120_bib11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1128\/AAC.36.3.558","article-title":"In vitro activity of sparfloxacin compared with those of five other quinolones","volume":"36","author":"Canton","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 6B","key":"10.1378\/chest.114.1.120_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(99)80303-9","article-title":"Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract","volume":"99","author":"Doern","year":"1995","journal-title":"Am J Med"},{"key":"10.1378\/chest.114.1.120_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0924-8579(94)90004-3","article-title":"The concentration of sparfloxacin in lung tissues after single and multiple doses","volume":"4","author":"Honeybourne","year":"1994","journal-title":"Int J Antimicrob Agents"},{"issue":"suppl","key":"10.1378\/chest.114.1.120_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/37.suppl_A.57","article-title":"A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses","volume":"37","author":"Wise","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.114.1.120_bib15","first-page":"1639","article-title":"Phase I study of pyridone carboxylic acid antibacterial agent, sparfloxacin","volume":"7","author":"Nakashima","year":"1991","journal-title":"Rinsho-Yakuri"},{"issue":"suppl","key":"10.1378\/chest.114.1.120_bib16","doi-asserted-by":"crossref","first-page":"A41","DOI":"10.1093\/jac\/37.suppl_A.41","article-title":"Pharmacokinetic interactions related to the chemical structures of fluoroquinolones","volume":"37","author":"Mizuki","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"10 suppl","key":"10.1378\/chest.114.1.120_bib17","first-page":"S","article-title":"The effect of sparfloxacin on the steady-state pharmacokinetics of digoxin in healthy male volunteers","volume":"11","author":"Johnson","year":"1994","journal-title":"Pharm Res"},{"key":"10.1378\/chest.114.1.120_bib18","unstructured":"Jonkman J, Crijns H, Surtees M. Phase I, open study of the effect of sparfloxacin (400 mg for 1 day followed by 200 mg for a further 6 days) on warfarin pharmacodynamics in 10 healthy volunteers. (Protocol AT-113). July 2, 1993; unpublished data; Rh\u00f4ne-Poulenc Rorer"},{"key":"10.1378\/chest.114.1.120_bib19","first-page":"585","article-title":"Cimetidine does not alter sparfloxacin pharmacokinetics","volume":"33","author":"Gries","year":"1995","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1378\/chest.114.1.120_bib20","first-page":"234","article-title":"Pharmacokinetics and clinical studies on sparfloxacin","volume":"39","author":"Shimada","year":"1991","journal-title":"Chemotherapy"},{"issue":"suppl","key":"10.1378\/chest.114.1.120_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jac\/37.suppl_A.161","article-title":"Overview of electrocardiographic and cardiovascular safety data for sparfloxacin","volume":"37","author":"Jaillon","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.114.1.120_bib22","first-page":"169","article-title":"The clinician and the microbiology laboratory","author":"Woods","year":"1995"},{"key":"10.1378\/chest.114.1.120_bib23","unstructured":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3rd ed; approved standard. NCCLS Document M7-A3 (vol 13), No. 25, 1993"},{"key":"10.1378\/chest.114.1.120_bib24","unstructured":"Performance standards for antimicrobial disk susceptibility tests. 5th ed; approved standard. NCCLS Document M2-A5 (vol 13), No. 24, 1993"},{"key":"10.1378\/chest.114.1.120_bib25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/174.5.986","article-title":"The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System","volume":"174","author":"Butler","year":"1996","journal-title":"J Infect Dis"},{"issue":"suppl 6A","key":"10.1378\/chest.114.1.120_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0002-9343(91)90318-R","article-title":"Use of quinolones for the treatment of acute bacterial exacerbations of chronic bronchitis","volume":"91","author":"Chodosh","year":"1991","journal-title":"Am J Med"},{"key":"10.1378\/chest.114.1.120_bib27","first-page":"245","article-title":"A multicenter double-blind comparative study of sparfloxacin and ofloxacin in the treatment of chronic respiratory tract infections [abstract 878]","author":"Hara","year":"1991","journal-title":"31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Sept 29-Oct 2"},{"issue":"suppl 3","key":"10.1378\/chest.114.1.120_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00003495-199300453-00175","article-title":"Clinical response of sparfloxacin in respiratory tract infections","volume":"45","author":"Soejima","year":"1993","journal-title":"Drugs"},{"key":"10.1378\/chest.114.1.120_bib29","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1378\/chest.110.6.1499","article-title":"Oral empiric treatment of community-acquired pneumonia: a multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin","volume":"110","author":"Ortqvist","year":"1996","journal-title":"Chest"},{"issue":"suppl l","key":"10.1378\/chest.114.1.120_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00003495-198700341-00018","article-title":"Ofloxacin in respiratory tract infections: a review of the results of clinical trials in Japan","volume":"34","author":"Saito","year":"1987","journal-title":"Drugs"},{"issue":"suppl l","key":"10.1378\/chest.114.1.120_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2165\/00003495-198700341-00017","article-title":"Clinical efficacy of ofloxacin in lower respiratory tract infections","volume":"34","author":"Grassi","year":"1987","journal-title":"Drugs"},{"issue":"suppl D","key":"10.1378\/chest.114.1.120_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/26.suppl_D.75","article-title":"A double-blind comparison of low dose ofloxacin and amoxycillin\/clavulanic acid in acute exacerbations of chronic bronchitis","volume":"26","author":"Rademaker","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 2","key":"10.1378\/chest.114.1.120_bib33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003495-199500492-00061","article-title":"Antichlamydial activities of newly developed fluoroquinolones and their potential future role in the treatment of chlamydial respiratory infections","volume":"49","author":"Soejima","year":"1995","journal-title":"Drugs"},{"issue":"suppl 3","key":"10.1378\/chest.114.1.120_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00003495-199300453-00016","article-title":"Quinolones in the treatment of lower respiratory tract infections in adult patients","volume":"45","author":"Carbon","year":"1993","journal-title":"Drugs"},{"key":"10.1378\/chest.114.1.120_bib35","first-page":"621","article-title":"Chronic bronchitis: role of antibiotics","author":"Isada","year":"1994"},{"key":"10.1378\/chest.114.1.120_bib36","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0002-9343(96)00255-0","article-title":"Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course","volume":"101","author":"Marrie","year":"1996","journal-title":"Am J Med"},{"issue":"suppl 2","key":"10.1378\/chest.114.1.120_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00003495-199500492-00026","article-title":"Fluoroquinolone toxicities: an update","volume":"42","author":"Lietman","year":"1995","journal-title":"Drugs"},{"key":"10.1378\/chest.114.1.120_bib38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2165\/00003088-199325050-00002","article-title":"Clinical pharmacokinetics of sparfloxacin","volume":"25","author":"Shimada","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"10.1378\/chest.114.1.120_bib39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF01964420","article-title":"Intracellular distribution and activity of antibiotics","volume":"10","author":"Tulkins","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"suppl l","key":"10.1378\/chest.114.1.120_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00003495-198700341-00009","article-title":"Diffusion of ofloxacin into human lung tissue","volume":"34","author":"Couraud","year":"1987","journal-title":"Drugs"},{"key":"10.1378\/chest.114.1.120_bib41","year":"1997"},{"issue":"suppl D","key":"10.1378\/chest.114.1.120_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jac\/26.suppl_D.55","article-title":"Ofloxacin concentrations in tissues involved in respiratory tract infections","volume":"26","author":"Perea","year":"1990","journal-title":"J Antimicrob Chemother"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215476275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215476275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T10:30:08Z","timestamp":1546338608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215476275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,7]]}},"alternative-id":["S0012369215476275"],"URL":"https:\/\/doi.org\/10.1378\/chest.114.1.120","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1998,7]]}}}